SCALA BIOGRAFEN SVENDBORG ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  1.1% 2.1% 1.1% 1.1% 1.8%  
Credit score (0-100)  86 66 83 83 70  
Credit rating  A BBB A A A  
Credit limit (kDKK)  479.7 0.3 349.2 252.6 2.2  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  5,632 3,664 4,324 5,002 5,453  
EBITDA  2,090 496 1,479 2,032 2,293  
EBIT  1,819 210 1,250 1,830 2,117  
Pre-tax profit (PTP)  2,174.3 -38.8 1,257.0 1,931.0 2,417.0  
Net earnings  1,695.7 -30.6 980.0 1,506.0 1,885.2  
Pre-tax profit without non-rec. items  2,174 -38.8 1,257 1,931 2,417  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  830 433 1,106 903 728  
Shareholders equity total  5,584 3,553 4,534 6,040 2,925  
Interest-bearing liabilities  2,594 2,504 2,341 4,595 6,348  
Balance sheet total (assets)  12,159 8,983 10,134 14,680 13,345  

Net Debt  -7,450 -3,307 -3,053 4,549 6,302  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  5,632 3,664 4,324 5,002 5,453  
Gross profit growth  0.2% -34.9% 18.0% 15.7% 9.0%  
Employees  8 7 7 8 8  
Employee growth %  0.0% -12.5% 0.0% 14.3% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  12,159 8,983 10,134 14,680 13,345  
Balance sheet change%  21.4% -26.1% 12.8% 44.9% -9.1%  
Added value  2,090.4 496.0 1,479.0 2,059.0 2,292.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -457 -682 444 -405 -351  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  32.3% 5.7% 28.9% 36.6% 38.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  20.8% 3.4% 14.4% 18.4% 18.7%  
ROI %  31.0% 5.0% 21.3% 26.1% 26.3%  
ROE %  32.4% -0.7% 24.2% 28.5% 42.1%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  45.9% 39.6% 44.7% 41.1% 21.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -356.4% -666.7% -206.4% 223.9% 274.9%  
Gearing %  46.5% 70.5% 51.6% 76.1% 217.0%  
Net interest  0 0 0 0 0  
Financing costs %  6.0% 15.4% 4.9% 10.1% 3.7%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.7 1.6 1.6 1.6 1.2  
Current Ratio  1.7 1.6 1.6 1.6 1.2  
Cash and cash equivalent  10,044.1 5,811.3 5,394.0 46.0 45.8  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  1,417.5 2,949.6 3,240.0 5,137.0 2,196.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  261 71 211 257 287  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  261 71 211 254 287  
EBIT / employee  227 30 179 229 265  
Net earnings / employee  212 -4 140 188 236